Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U M Zanger

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 3, 2011
[Pharmacogenomics: hype or hope?]M Schwab, E Schaeffeler, U M Zanger, et al.
Progress in Liver Diseases|January 1, 1990
Genetic polymorphisms of drug metabolismU A Meyer, U M Zanger, R C Skoda, et al.
The Journal of Biological Chemistry|February 25, 1993
Cooperating nonconsensus cAMP-responsive elements are mediators of adrenocorticotropin-induced VL30 transcription in steroidogenic adrenal cellsS Bohm, M Bakke, M Nilsson, et al.
Pharmacogenetics|October 1, 1996
Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reactionT Stüven, E U Griese, H K Kroemer, et al.
The Pharmacogenomics Journal|November 5, 2003
Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomesP C Ho, F S Abbott, U M Zanger, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1996
Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approachP Fritz, E Behrle, U M Zanger, et al.
Molecular Endocrinology (Baltimore, Md.)|September 1, 1993
Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BPK Morohashi, U M Zanger, S Honda, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type IIU M Zanger, H P Hauri, J Loeper, et al.
Pharmacogenetics|October 19, 2000
Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6S Raimundo, J Fischer, M Eichelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: a retrospective exploratory study with long-term follow-upP Fritz, T E Mürdter, M Eichelbaum, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Deutsche Medizinische Wochenschrift (1946)|March 3, 2011
[Pharmacogenomics: hype or hope?]M Schwab, E Schaeffeler, U M Zanger, et al.
Progress in Liver Diseases|January 1, 1990
Genetic polymorphisms of drug metabolismU A Meyer, U M Zanger, R C Skoda, et al.
The Journal of Biological Chemistry|February 25, 1993
Cooperating nonconsensus cAMP-responsive elements are mediators of adrenocorticotropin-induced VL30 transcription in steroidogenic adrenal cellsS Bohm, M Bakke, M Nilsson, et al.
Pharmacogenetics|October 1, 1996
Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reactionT Stüven, E U Griese, H K Kroemer, et al.
The Pharmacogenomics Journal|November 5, 2003
Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomesP C Ho, F S Abbott, U M Zanger, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1996
Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approachP Fritz, E Behrle, U M Zanger, et al.
Molecular Endocrinology (Baltimore, Md.)|September 1, 1993
Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BPK Morohashi, U M Zanger, S Honda, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type IIU M Zanger, H P Hauri, J Loeper, et al.
Pharmacogenetics|October 19, 2000
Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6S Raimundo, J Fischer, M Eichelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: a retrospective exploratory study with long-term follow-upP Fritz, T E Mürdter, M Eichelbaum, et al.
Pageof 6